Anna Laromaine
Overview
Explore the profile of Anna Laromaine including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
622
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ruiz-Solani N, Alonso-Diaz A, Capellades M, Serrano-Ron L, Ferro-Costa M, Sanchez-Corrionero A, et al.
Sci Adv
. 2025 Feb;
11(7):eadr1509.
PMID: 39937889
Regeneration is a unique feature of postembryonic development extensively observed in plants. The capacity to induce regeneration exogenously is limited and usually confined to meristematic-like tissues. We show that bacterial...
2.
Carenza E, Barcelo V, Morancho A, Levander L, Boada C, Laromaine A, et al.
Nanomedicine
. 2024 Oct;
62:102793.
PMID: 39427566
No abstract available.
3.
El Moukhtari S, Munoz-Juan A, Del Campo-Montoya R, Laromaine A, Blanco-Prieto M
Drug Deliv Transl Res
. 2024 Mar;
14(8):2170.
PMID: 38459422
No abstract available.
4.
Munoz-Juan A, Assie A, Esteve-Codina A, Gut M, Benseny-Cases N, Samuel B, et al.
Carbohydr Polym
. 2024 Feb;
331:121815.
PMID: 38388067
Bacterial nanocellulose (BNC) is a promising dietary fiber with potential as a functional food additive. We evaluated BNC fibers (BNCf) in the Caenorhabditis elegans model to obtain insight into the...
5.
El Moukhtari S, Munoz-Juan A, Del Campo-Montoya R, Laromaine A, Blanco-Prieto M
Drug Deliv Transl Res
. 2024 Feb;
14(8):2158-2169.
PMID: 38363484
Neuroblastoma is a pediatric tumor that originates during embryonic development and progresses into aggressive tumors, primarily affecting children under two years old. Many patients are diagnosed as high-risk and undergo...
6.
Schroter L, Jentsch L, Maglioni S, Munoz-Juan A, Wahle T, Limke A, et al.
Small
. 2023 Oct;
20(10):e2302907.
PMID: 37899301
Exposure to plastic nanoparticles has dramatically increased in the last 50 years, and there is evidence that plastic nanoparticles can be absorbed by organisms and cross the blood-brain-barrier (BBB). However,...
7.
Munoz-Juan A, Nuez-Martinez M, Laromaine A, Vinas C
Chemistry
. 2023 Oct;
30(4):e202302484.
PMID: 37870209
Cobaltabis(dicarbollides), ferrabis(dicarbollide), and their halogenated derivatives are the most studied metallacarboranes with great medical potential. These versatile compounds and their iodinated derivatives can be used in chemotherapy, radiotherapy, particle therapy,...
8.
Malandain N, Sanz-Fraile H, Farre R, Otero J, Roig A, Laromaine A
ACS Appl Bio Mater
. 2023 Sep;
6(9):3638-3647.
PMID: 37669535
There is a growing interest in developing natural hydrogel-based scaffolds to culture cells in a three-dimensional (3D) millieu that better mimics the cells' microenvironment. A promising approach is to use...
9.
Srinivasan S, Illera P, Kukhtar D, Benseny-Cases N, Ceron J, Alvarez J, et al.
ACS Nano
. 2023 Aug;
17(17):17273-17284.
PMID: 37624669
Experimental studies and clinical trials of nanoparticles for treating diseases are increasing continuously. However, the reach to the market does not correlate with these efforts due to the enormous cost,...
10.
Petroulakis N, Mattsson M, Chatziadam P, Simko M, Gavrielides A, Yiorkas A, et al.
Int J Environ Res Public Health
. 2023 Jun;
20(12).
PMID: 37372672
The evolution of emerging technologies that use Radio Frequency Electromagnetic Field (RF-EMF) has increased the interest of the scientific community and society regarding the possible adverse effects on human health...